Executive Director Bristol Myers Squibb New Brunswick, New Jersey
Join Otilia Koo and several authors in Poster Forum #7 in the Solution Center for a conversation about posters on the topic, “Accelerating drug development and innovations”, that she is especially excited about.
M1330-06-40 A Comprehensive Bioanalytical Strategy of In Vivo Studies for RNAi Therapeutics in Early Discovery, Nan Zhao, Ph.D., WuXi AppTec (Shanghai) Co., Ltd.
M1430-12-77 A Rational and Data-Driven Approach to Formulation of Therapeutic Peptides, Tania Lind, Ph.D., Bioneer A/S
W0930-09-58 Continuous Wet Granulation and Drying: Moving from Technical Feasibility to Commercial Scale, Colton Bower, M.S., Merck & Co., Inc.
M0930-10-67 Past-to-Present Comparison of Repeat Analysis-Related Observations in Pharmacokinetic Bioequivalence Studies Submitted in Abbreviated New Drug Applications, Alaa AbuZnait, Ph.D., US Food and Drug Administration
M1330-10-65 Quantifying Clinical Trial Diversity of New Drugs Approved by the FDA, Kay Olmstead, Ph.D., Nano ParmaSolutions
T1430-09-59, Regulatory Experience with Continuous Manufacturing and Real Time Release Testing for Dissolution in New Drug Applications, Maziar Kakhi, Ph.D., US Food and Drug Administration